Novel liquid biopsy technology to change the way we manage cancer
San Francisco/San Diego, CA
Joined December 2016
- Tweets73
- Following53
- Followers220
- Likes62
Today, we are proud to join @FoundationATCG, and to work together to change the way we understand and treat cancer businesswire.com/news/home/2…
Lexent Bio retweeted
Don’t miss Nicole Lambert from @lexentbio in the Bronze sponsor workshop: "Monitoring cell-free methylation changes with enzymatic conversion to assess response to cancer treatments." Tuesday, Feb 25th, 3:15-3:30 PM. nebiolabs.com/AGBT20
#RNAseq #AGBT20
Lexent Bio retweeted
How will genome profiling change the standard-of-care in the near and/or far future? Ted Snelgrove, @lexentbio, answered. Check it out.
Plus, only 10 days till #PMWC20! Tickets: pmwcintl.com
pmwcintl.com/ted-snelgrove-2…
#genome #healthcare
Proud to be part of this great initiative focr.org/news/friends-cancer…
Allen on ctMoniTR: “Working with multiple partners will develop the necessary evidence about the use of ctDNA in a way that is faster and more robust than if everyone continues to investigate it independently."
To learn more about our new project, visit: bit.ly/2NBVwzB
Proud to be partnering with @illumina towards making Lexent response monitoring technology available as an IVD kit
We are excited to partner with @lexentbio to develop an in vitro next-generation sequencing-based cancer diagnostic kit: bddy.me/2Q5PjNU
Thanks for hosting this great workshop at #ASHG2019 - glad we could play a part!
Headed to #ASHG2019? Join us Thursday from 12:45-2pm for lunch and a workshop on "Advancing DNA Methylome Analysis" with presentations by Frank Wos of @nygenome and Nicole Lambert of @lexentbio. Plus be entered to win an Apple Watch®! Register at nebiolabs.com/30NEvGa
#NEBNext
Lexent Bio retweeted
It was an honor to be selected by @rdienstmann, a pioneer and thought leader in this field. #ESMO2019 #ESMO19 #cfDNA. Great collaboration with @NUFeinbergMed @lexentbio
Lexent Bio technology provides molecular response early in the course of cancer treatment. Liquid Biopsies Intensify Surveillance of ctDNA genengnews.com/insights/liqu… via @GENbio
Lexent Bio retweeted
Liquid Biopsy Weekly: Spotlight on @lexentbio - study of 97 patients detects disease progression ~6 weeks before imaging, with Sn 54% and Sp 100%
Read more about this week's exciting activities in the #liquidbiopsy space here: bit.ly/2ZbQCQF
#ctDNA #decibio #weeklynews
Excellent reporting on our preprint manuscript @GenomeWeb genomeweb.com/liquid-biopsy/…
Our preprint is now available on @medrxivpreprint: Early detection of molecular disease progression by whole-genome circulating tumor DNA in advanced solid tumors medrxiv.org/content/10.1101/…
Thanks for the shout-out @vintweeta, and for your contributions to this space
Optimistic about the work that @GrailBio @freenome @GuardantHealth @FoundationATCG @lexentbio and so many others are doing to systematically change the timepoints at which we acquire information about new cancer diagnoses as well as progression/resistance to therapy.
It's a beautiful day in SF for the #liquidbiopsysummit today! Looking forward to CMO @htezcan’s talk, "Towards Marker-Driven Treatment Management in Patients with Advanced Cancer"
The lines to see our posters are long but the wait is worth it. Come see our remarkable response monitoring clinical data this morning at #ASCO2019
Come visit us at #ASCO19 poster session June 1, 8-11 an Hall A Board #33 (Abst #3041 abstracts.asco.org/239/AbstV…) & Board #34 (Abst #3042 abstracts.asco.org/239/AbstV…)
Great turnout & fun to discuss so many good questions about our work on response monitoring at #AACR2019
Our work "Serial changes in tumor-derived whole-genome cell-free DNA (cfDNA) fraction to identify early disease progression prior to imaging" that was presented at #AACR2019 #cfDNA #cancerresearch #WGS docs.wixstatic.com/ugd/ad98a…
Lexent Bio retweeted
HT: @lexentbio use whole genome signals including methylation, Sequence Variants, local read counts and fragment characteristics to determine if patient in remission or is progressing.
#PMWC19
We’re looking forward to #PMWC19 next week! Join our CMO Dr Haluk Tezcan @HTezcanMD in the liquid biopsy showcase, Jan 21st at 145pm, for "Avoiding Ineffective Treatment Cycles With Liquid Biopsy". Bio and more on the topic: pmwcintl.com/haluk-tezcan-20… #genomics #cancer